T. Bjork-eriksson et al., The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: Relationships with radiosensitivity, INT J RAD O, 45(4), 1999, pp. 1005-1010
Citations number
31
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: The DNA-PK complex is one of the major pathways by which mammalian
cells respond to DNA double-strand breaks induced by ionizing radiation. T
his study evaluated the relationship between the immunohistochemical expres
sion of the individual components of DNA-PK and cellular radiosensitivity i
n head and neck cancers,
Methods and Materials: Biopsies from patients with previously untreated squ
amous cell carcinomas of the head and neck were assessed for inherent tumor
radiosensitivity measured as the surviving fraction at 2 Gy (SF2) using a
soft agar clonogenic assay. Paraffin-embedded tumor material from 64 Succes
sfully grown specimens was immunohistochemically stained for expression of
DNA-PKcs and Ku (p70/p80), The same tumor material was previously analyzed
for the immunohistochemical expression of p53,
Results: A significant correlation was found between the degree of expressi
on of DNA-PKcs and Ku (p70/p80) (r = 0.55, p < 0.001). There were no overal
l significant differences in the levels of expression of DNA-PKcs and Ku (p
70/p80) in tumors from patients of either sex, different sites, histologies
, and stages. No relationship was found between SF, and the expression of e
ither DNA-PKcs (r = 0.22, p = 0.081) or Ku (p70/p80) (r = 0.064, p 0.62), C
omparison with previous immunohistochemical characterization showed no sign
ificant correlations between the expression levels of p53 and either DNA-PK
cs (r = 0.093,p = 0.46) or Ku (p70/p80) (p = -0.17,p 0.17).
Conclusions: This study suggests that determining the immunohistochemical e
xpression of DNA-PK in head and neck cancers from multiple sites does not h
ave a role as a predictive assay of tumor irt vitro radiosensitivity. (C) 1
999 Elsevier Science Inc.